NCT05094752

Brief Summary

"Spinal cord injury (SCI) is a dramatic event resulting in a long-term handicap. Appropriate care from admission to the intensive care unit (ICU) is a key element not only for the survival of these patients but also to promote their recovery. Moreover, the studies on natural history of SCI have shown that most of the recovery occurs within the first 3 to 6 months post-injury. This period is therefore crucial for these patients. However, the environment of the ICU and the acute condition of the patients limit the rehabilitation possibilities. In such a context, functional proprioceptive stimulations (Vibramoov™ system, Techno Concept, France) could be a tool of interest. By using tendon vibrations, the Vibramoov™ system allows to reproduce the proprioceptive signatures of cyclic movements such as walking. Some studies have already demonstrated the benefits of proprioceptive vibrations. However, so far, these benefits have only been studied at the chronic stage of neurological diseases. The investigators hypothesized that early functional proprioceptive stimulations (FPS) may reduce spasticity and promote sensorimotor recovery in tetraplegic and high paraplegic patients. To test their hypothesis, the investigators conduct a randomized controlled trial on 40 patients with traumatic SCI. These patients will be stratified into two groups according to the completeness of their lesion. Every patient will be included within ten days post-injury and receive either FPS, either sham stimulations to the joints of the lower limbs, 4 times a week during 8 weeks. the primary outcome measures will assess spasticity. the investigators also assess sensorimotor recovery, pain, muscle wasting, cognitive impairment and functional status. "

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 22, 2021

Completed
28 days until next milestone

Study Start

First participant enrolled

October 20, 2021

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 26, 2021

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 20, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 20, 2024

Completed
Last Updated

October 26, 2021

Status Verified

September 1, 2021

Enrollment Period

2.9 years

First QC Date

September 22, 2021

Last Update Submit

October 15, 2021

Conditions

Keywords

spinal cord injuriesquadriplegiaproprioceptive stimulationvibrationspasticityintensive care units

Outcome Measures

Primary Outcomes (4)

  • Changes in the modified Ashworth scale (MAS)

    The MAS enables to assess spasticity. The muscle whose spasticity will be assessed are the soleus, gastrocnemius, knee extensors, knee flexors, adductors and gracilis (Score range from 0 to 5 per muscle, higher values represent a higher severity of spasticity)

    Every week during the eight weeks of treatment, then at 2 months (end of treatment), 6 months and 1 year after the injury.

  • Changes in the angles of the muscle reaction in the modified Tardieu scale (MTS)

    The MTS enables to assess the severity of spasticity. The muscle whose spasticity will be assessed are the soleus, gastrocnemius, knee extensors, knee flexors, adductors and gracilis (The outcome is reported in degree, from 0 to 180 degrees, higher values represent a higher dynamic component of spasticity)

    Every week during the eight weeks of treatment, then at 2 months (end of treatment), 6 months and 1 year after the injury.

  • Changes in the quality of the muscle reaction in the modified Tardieu scale (MTS)

    The muscle whose spasticity will be assessed are the soleus, gastrocnemius, knee extensors, knee flexors, adductors and gracilis (Score range from 0 to 5 per muscle, higher values represent a higher severity of spasticity)

    Every week during the eight weeks of treatment, then at 2 months (end of treatment), 6 months and 1 year after the injury.

  • Changes in the Spinal cord assessment tool for spastic reflexes (SCATS)

    This score enables to asses global spasticity (Score range from 0 to 18, higher values represent a higher degree of spasticity)

    Every week during the eight weeks of treatment, then at 2 months (end of treatment), 6 months and 1 year after the injury.

Secondary Outcomes (12)

  • Changes in the visual analog scale for the auto-assessment of problematic spasticity

    Every week during the eight weeks of treatment, then at 2 months (end of treatment), 6 months and 1 year after the injury.

  • Changes in the visual analog scale for the auto-assessment of pain

    Every week during the eight weeks of treatment, then at 2 months (end of treatment), 6 months and 1 year after the injury

  • Changes in the International standards for neurological classification of spinal cord injury (ISNCSCI) score

    At inclusion, and at one week, one month, 2 months, 6 months and 1 year after the injury.

  • Changes in the quadriceps muscle thickness

    At inclusion, then twice a week during the first month, and at 2 months, 6 months and 1 year after the injury

  • Changes in the nitrogen balance,

    Every 48 hours during the first two weeks, and then once a week for six weeks

  • +7 more secondary outcomes

Study Arms (2)

Intervention group

EXPERIMENTAL

Vibration treatment will last eight weeks for each patient, with 4 sessions per week, 30 minutes per session. Subjects of the intervention group will receive proprioceptive stimulations set to create illusions of movement.

Device: Proprioceptive stimulations

Control group

SHAM COMPARATOR

Vibration treatment will last eight weeks for each patient, with 4 sessions per week, 30 minutes per session. Subjects of the control group will receive sham stimulations.

Device: Sham stimulations

Interventions

Vibration treatment will last eight weeks for each patient, with 4 sessions per week, 30 minutes per session. Subjects of the intervention group will receive proprioceptive stimulations set to create illusions of movement.

Intervention group

Vibration treatment will last eight weeks for each patient, with 4 sessions per week, 30 minutes per session. Subjects of the control group will receive sham stimulations.

Control group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Traumatic Spinal Cord Injury at or above level T6
  • Age ≥ 18 years old
  • No pregnancy
  • Not being under guardianship
  • Be affiliated to the French social security system

You may not qualify if:

  • Orthopedic lesions or any medical condition that prevent the implementation of the protocol within ten days post-injury
  • Severe brain injury

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bicêtre Hospital

Le Kremlin-Bicêtre, 94270, France

RECRUITING

Related Publications (1)

  • Martinache F, de Crouy AC, Boutin A, Duranteau J, Vigue B. Early functional proprioceptive stimulation in high spinal cord injury: a pilot study. Front Rehabil Sci. 2025 Feb 26;6:1490904. doi: 10.3389/fresc.2025.1490904. eCollection 2025.

MeSH Terms

Conditions

Spinal Cord InjuriesQuadriplegiaMuscle Spasticity

Condition Hierarchy (Ancestors)

Spinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemWounds and InjuriesParalysisNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMuscular DiseasesMusculoskeletal DiseasesMuscle HypertoniaNeuromuscular Manifestations

Study Officials

  • Bernard VIGUE

    APHP

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 22, 2021

First Posted

October 26, 2021

Study Start

October 20, 2021

Primary Completion

September 20, 2024

Study Completion

September 20, 2024

Last Updated

October 26, 2021

Record last verified: 2021-09

Data Sharing

IPD Sharing
Will not share

Locations